A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
Keyword(s):
De Novo
◽
2009 ◽
Vol 2
(12)
◽
pp. 1190-1198
◽
2010 ◽
Vol 77
(7)
◽
pp. 1012-1017
◽
2013 ◽
Vol 166
(6)
◽
pp. 1035-1042
◽